OpenVSafe by OpenVAERS
Search V-safe

2UY-46425-39444

1 vaccination 0 coded responses 6 check-ins 0 free-text entries 3 call cases
Sex
Female
Age at first dose
16-20
ZIP prefix
474 / IN
Registered
2021-03-29
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-29
    Registered in v-safe
  2. 2021-03-29
    Dose 1 — Janssen/Johnson & Johnson
  3. 2021-03-29
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  4. 2021-03-29
    Report sent to call center — day 0, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  5. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Muscle or body aches
    Adult check-in
  6. 2021-03-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  7. 2021-03-31
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  8. 2021-04-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  9. 2021-04-01
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  10. 2021-04-12
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-05-05
    Health check-in — day 35, single dose
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-29Janssen/Johnson & Johnson

Call center

ReportedOutcomeVAERS-related outcome
2021-03-29 priority 2/3
2021-03-31 priority 2/3
2021-04-01 priority 2/3

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

No MedDRA codes.

Loading…